Gyre Therapeutics
GYRE
GYRE
30 hedge funds and large institutions have $15M invested in Gyre Therapeutics in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5% more capital invested
Capital invested by funds: $14.3M → $15M (+$734K)
0.4% more ownership
Funds ownership: 1.07% → 1.47% (+0.4%)
Holders
30
Holding in Top 10
–
Calls
$1.04M
Puts
$15K
Top Buyers
| 1 | +$3.91M | |
| 2 | +$1.18M | |
| 3 | +$663K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$436K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$275K |
Top Sellers
| 1 | -$1.05M | |
| 2 | -$806K | |
| 3 | -$534K | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$244K |
| 5 |
JPMorgan Chase & Co
New York
|
-$203K |